BPC-157 is a stable gastric pentadecapeptide originally derived from human gastric juice, TB-500 is a synthetic p
So, in summary: FOXO4-DRI appears to represent the next-generation senolytic, offering improved specificity, but it is still earlier stage than many small-molecule senolytics or repurposed drug combinations
Discard the vial and start with a fresh one
The stack is always built on a clinical assessment, not a menu selection
The foundational peptide for whole-body restoration during menopause
GHK-Cu has a 1,000,000-fold window between observed effect and toxicity, which is one reason injectable forms have been used compounded under prescription for decades without major safety signals